Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 26
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Condray, Ruth Yao, Jeffrey K. Steinhauer, Stuart R. van Kammen, Daniel P. Reddy, Ravinder D. and Morrow, Lisa A. 2008. Semantic memory in schizophrenia: Association with cell membrane essential fatty acids. Schizophrenia Research, Vol. 106, Issue. 1, p. 13.

    Nadalin, S. Rubeša, G. Giacometti, J. Vulin, M. Tomljanović, D. Vraneković, J. Kapović, M. and Buretić-Tomljanović, A. 2008. BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 78, Issue. 6, p. 351.

    Isaac, Giorgis Fredriksson, Anders Danielsson, Rolf Eriksson, Per and Bergquist, Jonas 2006. Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice. FEBS Journal, Vol. 273, Issue. 10, p. 2232.

    Sinclair, Andrew Wallace, Julie Martin, Marion Attar-Bashi, Nadia Weisinger, Richard and Li, Duo 2005. Healthful Lipids.

    Skosnik, P.D. and Yao, J.K. 2003. From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?. Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 69, Issue. 6, p. 367.

    Mahadik, Sahebarao P. Evans, Denise and Lal, Harbns 2001. Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 25, Issue. 3, p. 463.

    Nishino, Seiji Mignot, Emmanuel Benson, Kathleen L and Zarcone, Jr, Vincent P 1998. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. Psychiatry Research, Vol. 78, Issue. 3, p. 141.

    Horrobin, David F. Manku, Mehar S. Morse-Fisher, Nancy Vaddadi, Krishna S. Courtney, Paul Glen, A.Iain M. Glen, Evelyne Spellman, M. and Bates, C. 1989. Essential fatty acids in plasma phospholipids in schizophrenics. Biological Psychiatry, Vol. 25, Issue. 5, p. 562.

    KAMMEN, DANIEL P. VAN YAO, JEFFREY K. and GOETZ, KENNETH 1989. Polyunsaturated Fatty Acids, Prostaglandins, and Schizophrenia. Annals of the New York Academy of Sciences, Vol. 559, Issue. 1 Arachidonie A, p. 411.

    Stein, George Robertson, Mary and Nadarajah, Jayasheerie 1988. Toxic interactions between lithium and non-steroidal anti-inflammatory drugs1. Psychological Medicine, Vol. 18, Issue. 03, p. 535.

    Caparrotta, L. Ceserani, R. Mongelli, N. Santi-Soncin, E. Ragazzi, E. and Fassina, G. 1987. Depression and exication induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation. Prostaglandins, Vol. 33, Issue. 3, p. 351.

    Horrobin, David F. 1987. Essential Fatty Acids, Prostaglandins, and Alcoholism: An Overview. Alcoholism: Clinical and Experimental Research, Vol. 11, Issue. 1, p. 2.

    Yeragani, V.K. and Chaitin, P. 1987. A prostaglandin theory of neuroleptic malignant syndrome. Medical Hypotheses, Vol. 24, Issue. 2, p. 143.

    Mathe, Aleksander A. Eberhard, Göran Sääf, Jan and Wetterberg, Lennart 1986. Plasma prostaglandin E2 metabolite—measured as 11 -deoxy-15 -keto-13,14-dihydro-11 β, 16ξ-cyclo-PGE2—in twins with schizophrenic disorder. Biological Psychiatry, Vol. 21, Issue. 11, p. 1024.

    Wilson, Donald W.S. and Douglass, Alan B. 1986. Niacin skin flush is not diagnostic of schizophrenia. Biological Psychiatry, Vol. 21, Issue. 10, p. 974.

    Whalley, L. J. Reading, H. W. and Rosie, R. 1984. ADP and arachidonic acid induced platelet aggregation in schizophrenia and atypical psychoses. Psychological Medicine, Vol. 14, Issue. 01, p. 207.

    Malek-Ahmadi, Parviz and Weddle, Margaret A. 1982. Schizophrenia and prostaglandins: Theories and therapeutic implications. General Pharmacology: The Vascular System, Vol. 13, Issue. 6, p. 467.

    Ragheb, Mohamed and Ban, Thomas A. 1982. Prostaglandins and schizophrenia: A review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 6, Issue. 2, p. 87.

    Rudin, Donald O. 1982. The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: Substrate beriberi. Medical Hypotheses, Vol. 8, Issue. 1, p. 17.



Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis

  • W. Feldberg (a1)
  • DOI:
  • Published online: 01 July 2009

Schizophrenia may be associated with increased prostaglandin synthesis in certain parts of the brain. This hypothesis is based on the following findings: (1) Catalepsy, which is the nearest equivalent in animals to human catatonia, develops in cats when prostaglandin E1 is injected into the cerebral ventricles and when during endotoxin or lipid A fever the prostaglandin E2 level in cisternal c.s.f. rises to high levels; however, when fever and prostaglandin level are brought down by non-steroid anti-pyretics which inhibit prostaglandin synthesis, catalepsy disappears as well. (2) Febrile episodes are a genuine syndrome of schizophrenia.

Corresponding author
1Address for correspondence: Professor W. Feldberg, National Institute for Medical Research, Mill Hill, London NW7 1AA.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

U. Banerjee , T. F. Burks , W. Feldberg & C. A. Goodrich (1968). Temperature effects of reserpine injected into the cerebral ventricles of rabbits and cats. Journal of Physiology 197, 221231.

G. L. Brown , B. Delisle Burns & W. Feldberg (1948). The effect of diisopropylfluorophosphonate on neuromuscular transmission in cats. Journal of Physiology 107, 346354.

D. E. Cameron (1934). Heat production and heat control in the schizophrenia reaction. Archives of Neurology and Psychiatry, Chicago 32, 704732.

W. I. Cranston , R. F. Hellon & D. Mitchell (1975). A dissociation between fever and prostaglandin concentration in cerebrospinal fluid. Journal of Physiology 253, 583592.

P. K. Dey , W. Feldberg , K. P. Gupta , A. S. Milton & W. Wendlandt (1974). Further studies on the role of prostaglandin in fever. Journal of Physiology 241, 629646.

P. K. Dey , W. Feldberg , K. P. Gupta & S. Wendlandt (1975). Lipid A fever in cats. Journal of Physiology 253, 103119.

W. Feldberg & K. P. Gupta (1973). Pyrogen fever and prostaglandin activity in cerebrospinal fluid. Journal of Physiology 228, 4153.

W. Feldberg & P.N. Saxena (1971). Fever produced by prostaglandin E1. Journal of Physiology 217, 547556.

R. J. Flower & J. R. Vane (1972). Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature 240, 410411.

R. J. Flower & J. R. Vane (1974). Inhibition of prostaglandin synthesis. Biochemical Pharmacology 23, 14391450.

R. Gjessing (1953/1954). Beiträge zur Somatologie der periodis-chen Katatonic. Mitteilung V-VIII. Archiv für Psychiatric und Nervenkrankheiten 191, 191219, 220–246, 247–296, 297–326.

D. Grob (1956). The manifestations and treatment of poisoning due to nerve gas and other organic anticholinesterase compounds. Archives of Internal Medicine 98, 221239.

D. Grob & J. C. Harvey (1958). Effects in man of the anticholinesterase sarin (isopropyl methyl phosphonofluori-date). Journal of Clinical Investigation 37, 350368.

S. W. Holmes & E. W. Horton (1968). The distribution of tritium labelled prostaglandin E1 in amounts sufficient to produce central nervous effects in cats and chicks. British Journal of Pharmacology 34, 3237.

E. W. Horton (1964). Action of prostaglandin E1, E2 and E3 on the central nervous system. British Journal of Pharmacology and Chemotherapy 22, 189192.

E. W. Horton & I. H. M. Main (1967). Identification of prostaglandins in central nervous tissues of the cat and chicken. British Journal of Pharmacology and Chemotherapy 30, 582602.

W. R. Ingram , R. W. Barris & S. W. Ranson (1936). Catalepsy: experimental study. Archives of Neurology and Psychiatry, Chicago 35, 11751197.

G. Jefferson (1938). Tentorial pressure cone. Archives of Neurology and Psychiatry, Chicago 40, 857876.

F.-W. Kroll (1935). Hauttemperaturmessunge bei zentralen Fieberstörungen. Deutsche Zeitschrift für Nervenheilkunde 135, 232245.

P. Krupp & M. Wesp (1975). Inhibition of prostaglandin synthetase by psychotropic drugs. Experientia 31, 330331.

A. S. Milton & Sabine Wendlandt (1971). Effects on body temperature of prostaglandins of the A, E, and F series on injection into the third ventricle of unanaesthetized rats and rabbits. Journal of Physiology 218, 325336.

R. Peele & I. von Loeken (1973). Phenothiazine deaths: A critical review. American Journal of Psychiatry 130, 306309.

W. K. Philipp-Dormston & R. Siegert (1974). Prostaglandins of the E and F series in rabbit cerebrospinal fluid during fever induced by Newcastle disease virus, E. coli-endotoxin, or endogenous pyrogen. Medical Microbiology and Immunology 159, 279284.

P. Piper & J. Vane (1971). The release of prostaglandins from lung and other tissues. Annals of the New York Academy of Sciences 180, 363385.

D. W. Rowntree , S. Nevin & A. Wilson (1950). The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis. Journal of Neurology and Psychiatry 13, 4762.

O. Westphal (1975). Bacterial endotoxins. International Archives of Allergy and Applied Immunology 49, 143.

A. L. Willis , P. Davison , P. W. Ramwell , W. E. Brocklehurst & B. Smith (1972). Release and actions of prostaglandins in inflammation and fever: Inhibition by anti-inflammatory and antipyretic drugs. In Prostaglandins in Cellular Biology (ed. P. W. Ramwell & B. B. Pharris ), pp. 227259. Plenum Press: New York.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *